
AstraZeneca’s antibody therapy prevents Covid-19, study shows
AstraZeneca’s new antibody therapy reduced the risk of people developing COVID-19 symptoms by 77% in a late-stage trial, putting the drugmaker on track to offer protection to those who respond ...